# A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitis

> **NCT02345928** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 108 (actual)

## Conditions studied

- Asthma
- Atopic Dermatitis
- Healthy

## Interventions

- **DRUG:** Part 1: CNTO 7160
- **DRUG:** Part 2 (Asthma): CNTO 7160
- **DRUG:** Part 2 (Atopic Dermatitis): CNTO 7160
- **DRUG:** Part 1 and Part 2: Placebo

## Key facts

- **NCT ID:** NCT02345928
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-05
- **Primary completion:** 2017-03-16
- **Final completion:** 2017-03-16
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2020-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02345928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02345928, "A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02345928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*